НовостиBenzingaValion Bio's Velocity Biowork Subsidiary Completes Initial Feasibility Evaluation Of LarmorBio's BioScan-NMR Platform Valion Bio's Velocity Biowork Subsidiary Completes Initial Feasibility Evaluation Of LarmorBio's BioScan-NMR Platform Benzinga 2026.10.15 12:01 (GMT+0) Открыть на Benzinga Другие новости